{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:15:59Z","timestamp":1777104959924,"version":"3.51.4"},"reference-count":117,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100003011","name":"Immune Deficiency Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["Z-01-AI-000432"],"award-info":[{"award-number":["Z-01-AI-000432"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.iac.2025.01.005","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T08:36:25Z","timestamp":1742373385000},"page":"267-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Navigating the Complexities of Common Variable Immunodeficiency Enteropathy"],"prefix":"10.1016","volume":"45","author":[{"given":"Joud","family":"Hajjar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Fuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2025.01.005_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.iac.2025.01.005_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40629-014-0030-4","article-title":"Immunodeficiency in adults a practical guide for the allergist","volume":"23","author":"Hausmann","year":"2014","journal-title":"Allergo J Int"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clim.2015.05.020","article-title":"Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders","volume":"160","author":"Van Schouwenburg","year":"2015","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.iac.2025.01.005_bib7","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaci.2016.08.030","article-title":"Noninfectious complications in patients with pediatric-onset common variable immunodeficiency correlated with defects in somatic hypermutation but not in class-switch recombination","volume":"139","author":"Almej\u00fan","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2025.01.005_bib9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.01.005_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11882-013-0350-3","article-title":"Autoimmunity in immunodeficiency","volume":"13","author":"Todoric","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.iac.2025.01.005_bib12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.14309\/ajg.0000000000000140","article-title":"A\u00a0high prevalence of gastrointestinal manifestations in common variable immunodeficiency","volume":"114","author":"Pikkarainen","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib14","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.iac.2025.01.005_bib15","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","article-title":"Gastrointestinal pathology in patients with common variable immunodeficiency and x-linked agammaglobulinemia","volume":"20","author":"Washington","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1572-0241.2003.07159.x","article-title":"Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients","volume":"98","author":"Luzi","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.iac.2025.01.005_bib18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/gut.35.9.1244","article-title":"Studies on the enteropathy associated with primary hypogammaglobulinaemia","volume":"35","author":"Teahon","year":"1994","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib19","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mi.2016.18","article-title":"Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation","volume":"9","author":"J\u00f8rgensen","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib20","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20140039","article-title":"Exhaustion of bacteria-specific CD4 T\u00a0cells and microbial translocation in common variable immunodeficiency disorders","volume":"211","author":"Perreau","year":"2014","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-018-0574-z","article-title":"Autoimmunity and inflammation in CVID: a possible crosstalk between immune activation, gut microbiota, and epigenetic modifications","volume":"39","author":"J\u00f8rgensen","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2025.01.005_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133220","article-title":"Leaky RAG deficiency in adult patients with impaired antibody production against bacterial polysaccharide antigens","volume":"10","author":"Geier","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.iac.2025.01.005_bib23","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3389\/fimmu.2019.01914","article-title":"Bacterial but not fungal gut microbiota alterations are associated with common variable immunodeficiency (CVID) phenotype","volume":"10","author":"Fiedorov\u00e1","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2025.01.005_bib24","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3389\/fimmu.2020.01654","article-title":"Altered microbiota, impaired quality of life, malabsorption, infection, and inflammation in CVID patients with diarrhoea","volume":"11","author":"Van Schewick","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2025.01.005_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671239","article-title":"Patients with common variable immunodeficiency (CVID) show higher gut bacterial diversity and levels of low-abundance genes than the healthy housemates","volume":"12","author":"Bos\u00e1k","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/1744666X.2019.1658523","article-title":"Malignancy in common variable immunodeficiency: a systematic review and meta-analysis","volume":"15","author":"Kiaee","year":"2019","journal-title":"Expet Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.01.005_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5858\/arpa.2017-0372-RS","article-title":"Gastrointestinal presentations of common variable immunodeficiency: hiding in plain sight","volume":"143","author":"Odetola","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"23","key":"10.1016\/j.iac.2025.01.005_bib28","first-page":"7007","article-title":"Incidence, management experience and characteristics of patients with giardiasis and common variable immunodeficiency","volume":"11","author":"D\u00edaz-Alberola","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab120","article-title":"Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review","volume":"29","author":"Bourque","year":"2022","journal-title":"J\u00a0Trav Med"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/trstmh\/tru005","article-title":"Diagnostic testing for Giardia infections","volume":"108","author":"Heyworth","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.iac.2025.01.005_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/CEG.S109123","article-title":"Autoimmune atrophic gastritis: current perspectives","volume":"10","author":"Minalyan","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.45.1.77","article-title":"Gastric pathology in patients with common variable immunodeficiency","volume":"45","author":"Zullo","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.iac.2025.01.005_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834137","article-title":"Contribution of helicobacter pylori to the inflammatory complications of common variable immunodeficiency","volume":"13","author":"Motta-Raymundo","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.01.005_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.iac.2025.01.005_bib35","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1016\/j.jaip.2023.06.050","article-title":"Clinical features, immunological characteristics, and treatment outcomes of campylobacter spp. infections in patients with common variable immunodeficiency","volume":"11","author":"Roa-Bautista","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.41.3.366","article-title":"Intravenous immunoglobulin therapy for severe Clostridium difficile colitis","volume":"41","author":"Salcedo","year":"1997","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ajg.2014.432","article-title":"The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency","volume":"110","author":"Woodward","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10875-022-01379-2","article-title":"Interferon-driven immune dysregulation in common variable immunodeficiency-associated villous atrophy and norovirus infection","volume":"43","author":"Strohmeier","year":"2023","journal-title":"J\u00a0Clin Immunol"},{"issue":"04","key":"10.1016\/j.iac.2025.01.005_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0032-1326078","article-title":"Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia","volume":"45","author":"Maarschalk-Ellerbroek","year":"2013","journal-title":"Endoscopy"},{"issue":"4","key":"10.1016\/j.iac.2025.01.005_bib40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaci.2009.06.018","article-title":"Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes","volume":"124","author":"Agarwal","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2025.01.005_bib41","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10620-006-9736-6","article-title":"Gastrointestinal manifestations in patients with common variable immunodeficiency","volume":"52","author":"Khodadad","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib42","first-page":"405","article-title":"Nodular lymphoid hyperplasia of the gastrointestinal tract : a comprehensive review","volume":"80","author":"Elkholy","year":"2017","journal-title":"Acta Gastro-Enterol Belg"},{"issue":"11","key":"10.1016\/j.iac.2025.01.005_bib43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4253\/wjge.v6.i11.534","article-title":"Nodular lymphoid hyperplasia in the gastrointestinal tract in adult patients: a review","volume":"6","author":"Albuquerque","year":"2014","journal-title":"World J Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(82)90938-X","article-title":"Diffuse follicular lymphoid hyperplasia of the small intestine without primary immunoglobulin deficiency","volume":"73","author":"Rambaud","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2025.01.005_bib45","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","article-title":"Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets","volume":"8","author":"Farmer","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2025.01.005_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fped.2019.00105","article-title":"Treatment-responsive granulomatous-lymphocytic interstitial lung disease in a pediatric case of common variable immunodeficiency","volume":"7","author":"Tillman","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.iac.2025.01.005_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606099","article-title":"Treatment strategies for GLILD in common variable immunodeficiency: a systematic review","volume":"12","author":"Lamers","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.iac.2025.01.005_bib48","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cgh.2013.02.024","article-title":"Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency","volume":"11","author":"Agarwal","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","article-title":"Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients","volume":"33","author":"Boursiquot","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"133","author":"Ardeniz","year":"2009","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.iac.2025.01.005_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606389","article-title":"What works when treating granulomatous disease in genetically undefined CVID? a systematic review","volume":"11","author":"Van Stigt","year":"2020","journal-title":"Front Immunol"},{"issue":"8423","key":"10.1016\/j.iac.2025.01.005_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(85)91037-2","article-title":"Prospective study of cancer in patients with hypogammaglobulinaemiA","volume":"325","author":"Kinlen","year":"1985","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study","volume":"130","author":"Mellemkj\u00e6r","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04384.x","article-title":"Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme","volume":"165","author":"Dhalla","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.iac.2025.01.005_bib56","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmi.2015.04.019","article-title":"Increased incidence of nitroimidazole-refractory giardiasis at the hospital for tropical diseases, London: 2008\u20132013","volume":"21","author":"Nabarro","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib57","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF02098467","article-title":"Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent Campylobacter jejuni infection","volume":"12","author":"Borleffs","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib58","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/infdis\/jiac085","article-title":"Clinical and in\u00a0vitro evidence favoring immunoglobulin treatment of a chronic norovirus infection in a patient with common variable immunodeficiency","volume":"226","author":"van Kampen","year":"2022","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cei.12884","article-title":"Chronic norovirus infection and common variable immunodeficiency","volume":"188","author":"Woodward","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2025.01.005_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1257398","article-title":"Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)","volume":"14","author":"Poto","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2025.01.005_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2018.09.008","article-title":"CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont","volume":"197","author":"Shulzhenko","year":"2018","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib62","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1572-0241.2007.01141.x","article-title":"Successful treatment of common variable immunodeficiency disorder-associated diarrhea with budesonide: a case report","volume":"102","author":"Elnachef","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib63","doi-asserted-by":"crossref","DOI":"10.4321\/S1130-01082009000300009","article-title":"Effective treatment of common variable immunodeficiency associated diarrhea","volume":"101","author":"C\u00f3rdova Guevara","year":"2009","journal-title":"Rev Esp Enferm Dig"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib64","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3904\/kjim.2014.29.2.256","article-title":"Successful treatment of enteropathy associated with common variable immunodeficiency","volume":"29","author":"Choi","year":"2014","journal-title":"Korean J Intern Med"},{"issue":"11","key":"10.1016\/j.iac.2025.01.005_bib65","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00002018-200831110-00002","article-title":"Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects","volume":"31","author":"Christensson","year":"2008","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000355957","article-title":"Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports","volume":"163","author":"Kralickova","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/106689690601400120","article-title":"Multimodal immunosuppressant therapy in steroid-refractory common variable immunodeficiency sprue: a case report complicating cytomegalovirus infection","volume":"14","author":"Medlicott","year":"2006","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib68","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2008.03891.x","article-title":"Oral budesonide for maintenance of remission of Crohn\u2019s disease: a pooled safety analysis","volume":"29","author":"Lichtenstein","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10875-023-01604-6","article-title":"CVID-Associated intestinal disorders in the USIDNET registry: an analysis of disease manifestations, functional status, comorbidities, and treatment","volume":"44","author":"Franzblau","year":"2024","journal-title":"J\u00a0Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4161\/mabs.3.6.17815","article-title":"Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders","volume":"3","author":"Benson","year":"2011","journal-title":"mAbs"},{"issue":"9","key":"10.1016\/j.iac.2025.01.005_bib71","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ecco-jcc\/jjx024","article-title":"Successful treatment of common variable immunodeficiency-associated inflammatory bowel disease with ustekinumab","volume":"11","author":"Ruiz De Morales","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"issue":"9","key":"10.1016\/j.iac.2025.01.005_bib72","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3390\/pathogens12091156","article-title":"Impact of treatment with ustekinumab on severe infections in a patient with uncontrolled psoriasis and late-onset combined primary immunodeficiency: case report","volume":"12","author":"Prestes-Carneiro","year":"2023","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/BOR.0000000000000491","article-title":"How does abatacept really work in rheumatoid arthritis?","volume":"30","author":"Bonelli","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib74","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/08820139.2020.1833029","article-title":"Evaluation of expression of LRBA and CTLA-4 proteins in common variable immunodeficiency patients","volume":"51","author":"Salami","year":"2022","journal-title":"Immunol Investig"},{"issue":"26","key":"10.1016\/j.iac.2025.01.005_bib75","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.12998\/wjcc.v11.i26.6176","article-title":"Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in CTLA4 gene: a case report","volume":"11","author":"Musabak","year":"2023","journal-title":"World J Clin Cases"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/acr.23824","article-title":"Risk of hospitalized infection and initiation of abatacept versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis: a propensity score-matched cohort study","volume":"72","author":"Chen","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib77","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/jrheum.120906","article-title":"Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program","volume":"40","author":"Weinblatt","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib78","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.2007.03481.x","article-title":"Anti-tumour necrosis factor-\u03b1 therapy for severe enteropathy in patients with common variable immunodeficiency (CVID)","volume":"150","author":"Chua","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib79","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000486448","article-title":"Common variable immunodeficiency-associated inflammatory enteropathy: the new era of biological therapy","volume":"25","author":"Arieira","year":"2018","journal-title":"GE Port J Gastroenterol"},{"issue":"5","key":"10.1016\/j.iac.2025.01.005_bib80","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4321\/S1130-01082013000500010","article-title":"Crohn\u2019s-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab","volume":"105","author":"V\u00e1zquez-Mor\u00f3n","year":"2013","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.iac.2025.01.005_bib81","doi-asserted-by":"crossref","DOI":"10.17235\/reed.2023.10032\/2023","article-title":"Effectiveness of infliximab in common variable immunodeficiency associated with enteropathy","author":"Quera","year":"2023","journal-title":"Rev Esp Enferm Dig"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.gastrohep.2017.03.002","article-title":"Infliximab como tratamiento de la enteropat\u00eda severa en un paciente con inmunodeficiencia com\u00fan variable e infecci\u00f3n por citomegalovirus","volume":"41","author":"Prieto Elordui","year":"2018","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1081-1206(10)61228-8","article-title":"Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature","volume":"95","author":"Thatayatikom","year":"2005","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2025.01.005_bib84","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ijc.31407","article-title":"Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions","volume":"143","author":"Calip","year":"2018","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.63","article-title":"Loss of response to anti-TNFs: definition, epidemiology, and management","volume":"7","author":"Roda","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"issue":"12","key":"10.1016\/j.iac.2025.01.005_bib86","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/ecco-jcc\/jjw092","article-title":"An overview of the mechanism of action of the monoclonal antibody vedolizumab","volume":"10","author":"Wyant","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.iac.2025.01.005_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108362","article-title":"Vedolizumab therapy in common variable immune deficiency associated enteropathy: a case series","volume":"212","author":"Sifers","year":"2020","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib88","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/ajg.2017.246","article-title":"Vedolizumab in patients with common variable immune deficiency and gut inflammation","volume":"112","author":"Boland","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib89","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000721","article-title":"Vedolizumab therapy in refractory enteropathy associated with CVID","volume":"9","author":"Johnson","year":"2022","journal-title":"ACG Case Rep J"},{"issue":"8","key":"10.1016\/j.iac.2025.01.005_bib90","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: old drug, new actions","volume":"111","author":"Maltzman","year":"2003","journal-title":"J\u00a0Clin Investig"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/apt.14133","article-title":"Immune modulator therapy for microscopic colitis in a case series of 73 patients","volume":"46","author":"Cotter","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 36","key":"10.1016\/j.iac.2025.01.005_bib92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2133.1990.tb02890.x","article-title":"Methotrexate side-effects","volume":"122","author":"Zachariae","year":"1990","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2025.01.005_bib93","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib94","first-page":"753","article-title":"Patients with CVID and autoimmune complications benefit from immunosuppressive treatment including mycophenolate mofetil","volume":"29","author":"Schroeder","year":"2009","journal-title":"J\u00a0Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2025.01.005_bib95","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/1744666X.2014.902314","article-title":"Secondary antibody deficiency","volume":"10","author":"Duraisingham","year":"2014","journal-title":"Expet Rev Clin Immunol"},{"issue":"2\u20133","key":"10.1016\/j.iac.2025.01.005_bib96","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0162-3109(00)00190-9","article-title":"The use of mycophenolate mofetil in transplant recipients","volume":"47","author":"Mele","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.iac.2025.01.005_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652487","article-title":"Common variable immunodeficiency and autoimmune diseases: a retrospective study of 95 adult patients in a single tertiary care center","volume":"12","author":"Mormile","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.iac.2025.01.005_bib98","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.anai.2019.07.014","article-title":"Autoimmunity in common variable immunodeficiency","volume":"123","author":"Agarwal","year":"2019","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.01.005_bib99","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjms.2017.03.014","article-title":"Methotrexate hepatotoxicity and the impact of nonalcoholic fatty liver disease","volume":"354","author":"Shetty","year":"2017","journal-title":"Am J Med Sci"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib100","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/ibd\/izy078","article-title":"Methotrexate for the treatment of pediatric crohn\u2019s disease: a systematic review and meta-analysis","volume":"24","author":"Colman","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.iac.2025.01.005_bib101","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2013.04.059","article-title":"Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series","volume":"132","author":"Noel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2025.01.005_bib102","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3109\/00365521.2012.719925","article-title":"IV Cyclosporine to treat refractory CVID enteropathy","volume":"47","author":"Sigmon","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.iac.2025.01.005_bib103","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.2007.06616.x","article-title":"Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency","volume":"138","author":"Kim","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.iac.2025.01.005_bib104","doi-asserted-by":"crossref","first-page":"235","DOI":"10.23822\/EurAnnACI.1764-1489.22","article-title":"New therapeutic approach by sirolimus for enteropathy treatment in patients with LRBA deficiency","volume":"49","author":"Azizi","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.01.005_bib105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/pai.12890","article-title":"Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T\u00a0cells","volume":"29","author":"Dey\u00e0-Mart\u00ednez","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"9","key":"10.1016\/j.iac.2025.01.005_bib106","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3174\/ajnr.A2226","article-title":"Natalizumab (Tysabri)","volume":"31","author":"Selewski","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.iac.2025.01.005_bib108","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s10875-023-01569-6","article-title":"JAK inhibition with baricitinib for severe CVID-related enteropathy: a case report","volume":"43","author":"Abdelmoumen","year":"2023","journal-title":"J\u00a0Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2025.01.005_bib109","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2006.06.022","article-title":"Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency","volume":"131","author":"Mannon","year":"2006","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/j.iac.2025.01.005_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144777","article-title":"Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency","volume":"6","author":"Ho","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.iac.2025.01.005_bib111","article-title":"Common variable immunodeficiency patient fecal microbiota transplant recapitulates gut dysbiosis","author":"Hajjar","year":"2023","journal-title":"Res Sq"},{"issue":"10","key":"10.1016\/j.iac.2025.01.005_bib112","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.tim.2020.04.011","article-title":"Label or concept - what is a pathobiont?","volume":"28","author":"Jochum","year":"2020","journal-title":"Trends Microbiol"},{"issue":"8","key":"10.1016\/j.iac.2025.01.005_bib113","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20180427","article-title":"IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria","volume":"215","author":"Nakajima","year":"2018","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.iac.2025.01.005_bib114","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri.2016.114","article-title":"Do antibodies select a healthy microbiota?","volume":"16","author":"Kubinak","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.01.005_bib115","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jaci.2018.09.036","article-title":"Synergistic convergence of microbiota-specific systemic IgG and secretory IgA","volume":"143","author":"Fadlallah","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.01.005_bib116","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s10238-023-01006-3","article-title":"Is there a role for microbiome-based approach in common variable immunodeficiency?","volume":"23","author":"Poto","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.iac.2025.01.005_bib117","first-page":"1","article-title":"Medically refractory IBD in a patient with CVID responsive to tofacitinib: a case report","volume":"6","author":"Waldron","year":"2024","journal-title":"SM J Gastroenterol Hepatol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856125000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856125000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:41:39Z","timestamp":1762314099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856125000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0889856125000050"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2025.01.005","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the Complexities of Common Variable Immunodeficiency Enteropathy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2025.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}